Ingerid Nesthus

Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.

A. B. Guttormsen, Per Magne Ueland, Ingerid Nesthus et al. · Journal of Clinical Investigation · 1996 · 261 citations · Full text

Life Sciences, Genetics, Nutritional Sciences +15

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Anders Waage, Peter Gimsing, Peter Fayers et al. · Blood · 2010 · 231 citations · Full text

Medicine, Hematology, Oncology +13

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B

Oddrun Elise Olsen, Karin Fahl Wader, Hanne Hella et al. · Cell Communication and Signaling · 2015 · 175 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

Peter Gimsing, Kristina Carlson, Ingemar Turesson et al. · The Lancet Oncology · 2010 · 118 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7

Health-Related Quality of Life in Multiple Myeloma Patients Receiving High-Dose Chemotherapy with Autologous Blood Stem-Cell Support

Nina Gulbrandsen, Lorentz Brinch, Kristina Carlson et al. · Medical Oncology · 2001 · 84 citations

Medicine, Hematology, Oncology +17